Award

Qihuang prize awarded to Mei Wang

Qihuang prize awarded to Mei Wang

In 2018, Dr. Mei Wang, chair of ‘Leiden University - European Center for Chinese Medicine and natural compounds’ has been awarded the ‘Qihuang prize’. The prize is awarded by the Chinese Medicine Society in recognition of her significant contribution to Chinese medicine outside China and to further stimulate her initiative and creativeness.

Dr. Mei Wang is the founder of the Leiden University - European Center for Chinese Medicine and natural compounds (LUECCM). The LUECCM is a virtual research center for studies on Chinese herbal medicine and natural compounds located in the Sylvius Laboratory and bringing together expertise from within the Institute of Biology Leiden (IBL) and Fytagoras, a 20 year old TNO-spin-off company specialised in horticulture and seed technology.

The best of two worlds combined The LUECCM brings together a variety of research projects by investigators from different scientific and cultural backgrounds. They target a better understanding of synergistic and opposing principles underlying Chinese herbal medicine and applications of natural compounds by combining the best of two worlds: scientific methods from the west and holistic knowledge from the east.

Mei Wang has been working for more than ten years for the European pharmacopoeia: a single reference work for the quality control of medicines in Europe and beyond. She contributed to about twenty monographs on Chinese herbal medicine. ‘It is an honor to receive the Qihuang prize and to be recognised for my work and activities,’ says Mei Wang.

The future... Wang will continue to contribute with dedication to the study, recognition and application of Chinese medicine outside China. ‘Scientific proof and insight into the underlying mechanisms is key for acceptance of Chinese herbal medicine in western society. It is my ambition that people from all over the world will have access to the benefits of this rich and valuable knowledge base’ - says Wang

Home

System medicine is the future of health care with herbal medicine playing an essential role

System medicine is the future of health care with herbal medicine playing an essential role

Perspective: The next generation Health care will aim at prevention or treatment of chronic diseases and health promotion. SU BioMedicine has cutting edge knowledge  and the research network for generating systems medicine for these developments. SU BioMedicine is a company with numerous collaborations and with all technology based research being performed in Europe. Its Chinese network is at a very high unique level, including  the government and the most innovative industries and research institutes in Chinese medicine in China.

Products portfolio: Chinese herbal medicine in treatment/ prevention of diseases in the area of pain, woman’s health, cold etc.

About us

Our History

Our History

SU BioMedicine (SUB) was established as a spin-off company from the Netherlands Applied Science ORGANISATION (TNO). SU BioMedicine is based on its unique expertise in Chinese Herbal Medicine with respect to quality, safety, efficiency, registration procedures in the European Union and commercialization in the EU. The business model of SU BioMedicine is to provide scientific evidence using modern scientific technologies/pharmacology and to perform registration and commercialization of the Chinese herbal products in the EU. SU BioMedicine collaborates with research institutions globally, for scientific evidence of the efficacy of Chinese herbal medicine and novel quality control. SU BioMedicine also works together with Chinese Medicine producers to arrange for EU GMP standards for production. SU BioMedicine is involved in establishment of Chinese herbal medicine monographs according to the European pharmacopeia quality standard. It functions as a bridge between Chinese and European pharmaceutical companies.

Mission
SU BioMedicine collaborates with scientific communities for scientific evidence and quality control of Chinese herbal medicine. SU BioMedicine also works together Chinese pharmaceutical companies and introduces Herbal Medicines on the European market as Herbal Medicine with scientific proven safety and efficacy to address the worldwide unmet medical need for treatment of various (chronic) diseases.

Technology

Our Expertise

Our Expertise

Extensive knowledge of EU regulatory aspects on herbal medicine, establishment of quality standards according European pharmacopeia monographs bridging Chinese and European approaches from scientific and cultural perspectives. Research on quality control, pharmacology and bioactivities of Chinese herbal medicines.

By cooperation with Leiden University-European Center for Chinese Medicine and Natural Compounds (LUECCM), as well as national and international restitutions SU BioMedicine established a scientific research platform in discovery and understanding of the molecular working mechanisms of Chinese herbal medicine and novel quality control technology. The scientific input can be used as a scientific evidence for acceptance of Chinese herbal products worldwide.

Products

DXXK

DXXK

SUB creates value by owning a portfolio of approved Chinese herbal medicine and by commercialization in EU.

Achievements: SU BioMedicine has realized, as the first company in the world, the registration of a Chinese medicinal product according to tHMP (traditional Herbal medicinal product) rules (directive 2004/24/EC) in Europe that is produced in China. A press conference was given on April 18, 2012 and organized by the Chinese government minister of Health Chen Zhu, the vice president of the National People’s congress San Guo Wei and the Chinese Academy of Sciences in the prestigious People’s Hall in Beijing. Present were 400 people from the press including CCTV.

Products portfolio: Chinese herbal medicine in treatment/ prevention of diseases in the area of pain, woman’s health, cold etc.

Contact Us

Please contact us:

Please contact us:

SU BioMedicine BV
Postbus 546
2300 AM Leiden
The Netherlands

E-mail: info@subiomedicine.com

News

Updates

Updates

April 2019 International Forum on Traditional Chinese Medicine and Botanical Medicine in Shenzhen, China: For more information please visit www.tcmbif.com

2018 SU BioMedicine established strategic partnership with Kaiwu TCM. For more information about Kaiwu TCM, please visit: kaiwutcm.com

October 2017 XIX Pharmaceutical Congress of São Paulo, Brazil

September 2017 Traditional Medicine International Cooperation Forum (2017 TMIF), Macao, China

2012 SU BioMedicine’s project with Diao was chosen as one of the 10 most scientific innovative achievements by the Chinese Academy of Sciences, Chinese Academy of Engineering, the Ministry of Science and Technology and the Nature Science foundation.